Vitasora Health Limited (ASX:VHL)
Australia · Delayed Price · Currency is AUD 0.0100
-0.0020 (-16.67%)
Jul 29, 2026, 2:30 PM AEST
Vitasora Health Financials Overview
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Revenue Revenue Growth | 5.01 | 3.71 | 1.04 | 0.66 | 0.77 | 1.39 |
Revenue Growth | 35.23% | 256.78% | 56.85% | -14.26% | -44.29% | -35.69% |
Gross Profit Gross Profit Growth | 5.21 | 3.68 | 1.03 | 0.6 | 0.51 | 0.12 |
Operating Income Operating Income Growth | -11.59 | -10.1 | -7.06 | -5.76 | -6.63 | -11.09 |
Net Income Net Income Growth | -11.59 | -10.11 | -7.13 | -5.78 | -6.62 | -11.04 |
Earnings Per Share EPS Growth | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Medical Devices - Australia Medical Devices - Australia Growth | 0.6 | 0.66 | 0.63 | 0.66 | 0.77 | 1.44 |
Corporate Corporate Growth | 0.01 | 0.01 | 0 | 0 | - | - |
Medical Devices - USA Medical Devices - USA Growth | 4.4 | 3.04 | - | - | - | - |
Medical Devices - Israel Medical Devices - Israel Growth | - | - | 0.41 | - | - | - |
Total Total Growth | 5.01 | 3.71 | 1.04 | 0.66 | 0.77 | 1.44 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Investments Cash & Investments Growth | 3.1 | 0.42 | 0.79 | 0.17 | 1.25 | 8.01 |
Total Debt Total Debt Growth | 0.03 | 0.06 | 0.12 | 0.15 | 0.07 | 0.14 |
Net Cash (Debt) Net Cash Growth | 3.07 | 0.36 | 0.67 | 0.03 | 1.18 | 7.87 |
Net Cash Growth | 748.06% | -46.37% | 2545.04% | -97.83% | -85.06% | 190.46% |
Net Cash Per Share Net Cash Per Share Growth | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -10.79 | -9.17 | -6.64 | -4.49 | -8.48 | -7.34 |
Capital Expenditures CapEx Growth | - | - | - | -0.02 | -0 | -0.05 |
Free Cash Flow Free Cash Flow Growth | -10.79 | -9.17 | -6.64 | -4.51 | -8.48 | -7.39 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Gross Margin | 103.94% | 99.19% | 99.63% | 90.09% | 66.42% | 8.84% |
Operating Margin | -231.37% | -272.69% | -680.22% | -870.00% | -858.74% | -800.27% |
Pretax Margin | -231.37% | -272.69% | -686.48% | -872.26% | -857.85% | -796.56% |
Profit Margin | -231.39% | -272.73% | -686.48% | -872.26% | -857.85% | -796.57% |
FCF Margin | -215.35% | -247.43% | -639.50% | -681.46% | -1098.15% | -533.43% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 29, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PS Ratio | 4.65 | 16.60 | 27.87 | 48.50 | 54.26 | 34.94 |